Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-031753
Filing Date
2021-12-16
Accepted
2021-12-16 18:00:17
Documents
1
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3975
  Complete submission text file 0001493152-21-031753.txt   5346
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18 BOSTON MA 02116
Business Address
Gillies Hunter (Reporting) CIK: 0001868997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 211498931